KCFA
Key Client Fiduciary Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Buy |
13,583
+10
| +0.1% | +$1.86K | 1.02% | 21 |
|
|
2025
Q1 | $2.84M | Sell |
13,573
-79
| -0.6% | -$16.6K | 1.29% | 16 |
|
|
2024
Q4 | $2.43M | Buy |
13,652
+14
| +0.1% | +$2.49K | 1.07% | 18 |
|
|
2024
Q3 | $2.69M | Sell |
13,638
-94
| -0.7% | -$18.6K | 1.21% | 15 |
|
|
2024
Q2 | $2.36M | Sell |
13,732
-756
| -5% | -$130K | 1.17% | 16 |
|
|
2024
Q1 | $2.64M | Sell |
14,488
-863
| -6% | -$157K | 1.4% | 15 |
|
|
2023
Q4 | $2.38M | Sell |
15,351
-1,164
| -7% | -$180K | 1.38% | 16 |
|
|
2023
Q3 | $2.46M | Buy |
16,515
+77
| +0.5% | +$11.5K | 1.51% | 18 |
|
|
2023
Q2 | $2.21M | Sell |
16,438
-184
| -1% | -$24.8K | 1.29% | 18 |
|
|
2023
Q1 | $2.65M | Buy |
16,622
+198
| +1% | +$31.6K | 1.65% | 15 |
|
|
2022
Q4 | $2.65M | Buy |
16,424
+13,719
| +507% | +$2.22M | 1.79% | 12 |
|
|
2022
Q3 | $363K | Buy |
2,705
+22
| +0.8% | +$2.95K | 0.33% | 64 |
|
|
2022
Q2 | $411K | Sell |
2,683
-60
| -2% | -$9.19K | 0.4% | 61 |
|
|
2022
Q1 | $445K | Sell |
2,743
-13
| -0.5% | -$2.11K | 0.35% | 63 |
|
|
2021
Q4 | $373K | Buy |
+2,756
| New | +$373K | 0.31% | 79 |
|